Tumor-LN-oC publishes end-user survey

The Tumor-LN-oC project (“Tumor and Lymph Node on Chip for cancer studies”) aims to offer a comprehensive solution for a robust, automated tumor-lymph node-on-chip platform that will connect primary surgically removed human tumors and LN tissue from the same cancer patient. This will allow to study the interaction of primary tumors with lymph nodes, identify their chemical signature, and offer personalized treatment relying on molecular characterization of lymph node metastasizing cells.

The Tumor-LN-oC Organ-on-Chip (OoC) platform to be developed is thus targeting the monitoring of complex processes such as tissue crosstalk and metastasis and will serve as a platform for parallel preclinical testing of drugs for individual patients aiming at Precision Medicine approaches.

In order to better understand the end-user requirements, the project team prepared a short questionnaire on end-users’ needs and requirements from an Organ-on-Chip (OoC) platform for metastasis diagnosis and drug testing. The survey includes questions related to the operation, the analysis time, the cost and other information that in the end will co-shape the platform that will be developed during the course of the project.

More information is available at https://tumor-ln-oc.eu/

If you or anyone you know would be interested in contributing, please fill out the questionnaire here and don’t hesitate to get in touch with the team. The Tumor-LN-oC consortium thanks you for your participation!